✦ LIBER ✦

Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy

✍ Scribed by Sparks, C A; Guertin, D A

Book ID: 109972345
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 658 KB
Volume: 29
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2010.139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

mTOR Pathway and mTOR Inhibitors in Canc

mTOR Pathway and mTOR Inhibitors in Cancer Therapy

✍ Marc S. Ernstoff 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

Mechanisms of mTOR inhibitor resistance

Mechanisms of mTOR inhibitor resistance in cancer therapy

✍ Jennifer S. Carew; Kevin R. Kelly; Steffan T. Nawrocki 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 298 KB

mTOR signaling is a possible new biochem

mTOR signaling is a possible new biochemical target for pancreatic cancer therapy

✍ D. Ito; K. Fujimoto; R. Doi; E. Toyoda; T. Mori; K. Kami; Y. Shimada; M. Imamura 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 158 KB

mTOR Inhibitors Synergize in Hepatocellu

mTOR Inhibitors Synergize in Hepatocellular Carcinoma

✍ Euler, M.; Wang, Y.; Otto, P.; Tomaso, H.; Escudero, R.; Anda, P.; Hufert, F. T. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 1010 KB

Future directions of mammalian target of

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

✍ Sumanta Kumar Pal; Robert A. Figlin 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 323 KB

Targeting downstream effectors of epider

Targeting downstream effectors of epidermal growth factor receptor/HER2 in breast cancer with either farnesyltransferase inhibitors or mTOR antagonists

✍ S.R.D. JOHNSTON 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB